Previous Article | Next Article 
J Virol, January 1998, p. 113-120, Vol. 72, No. 1
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Tracking Members of the Simian Immunodeficiency
Virus deltaB670 Quasispecies Population In Vivo at Single-Cell
Resolution
Todd A.
Reinhart,1,
Michael J.
Rogan,1
Angela Martin
Amedee,2
Michael
Murphey-Corb,2
Dianne M.
Rausch,3
Lee E.
Eiden,4 and
Ashley T.
Haase1,*
Department of Microbiology, University of
Minnesota Medical School, Minneapolis, Minnesota
554551;
Tulane Regional Primate
Research Center, Covington, Louisiana 704332;
Office on AIDS, National Institute of Mental Health,
Rockville, Maryland 208573; and
Laboratory of Cell Biology, National Institute of Mental
Health, Bethesda, Maryland 208544
Received 18 July 1997/Accepted 1 October 1997
 |
ABSTRACT |
Genetically distinct lentiviruses constitute a quasispecies
population that can evolve in response to selective forces. To move
beyond characterization of the population as a whole to the behavior of
individual members, we devised an in situ hybridization approach that
uses genotype-specific probes. We used probes that detect simian
immunodeficiency viruses (SIV) that differ in sequence in the V1 region
of the surface envelope glycoprotein (env) gene to
investigate the replication and cellular tropisms of four viral variants in the tissues of infected rhesus macaques. We found that the
V1 genotypic variants replicated in spatially defined patterns and to
different extents at each anatomic site. The two variants that
replicated most extensively in animals with AIDS were detected in both
macrophages and T lymphocytes in tissues. By extension of this
approach, it will be possible to investigate the role of individual
lentiviruses in a quasispecies in pathogenesis and to evaluate the
effects of antiviral or immunotherapeutic treatment on select members
of a quasispecies.
 |
INTRODUCTION |
Genetic variation of the
lentiviruses is thought to play a major role in transmission
(42), development of immunodeficiency (37, 41)
and neurological disease (33), escape from host defenses
(39), and resistance to antiviral drugs (28).
Differences, for example, in regions of the lentivirus env
gene that are correlated with the ability to replicate in cultured
macrophages are also correlated with the macrophage tropism of virus
strains that successfully transmit infection (22) and with
replication in macrophages and microglia in the nervous system
(16). In later stages of infection, evolution of genetic
diversity in the env gene of human and simian
immunodeficiency viruses (HIV and SIV, respectively) is associated with
poor growth in cultured macrophages but rapid growth with induction of
syncytia (syncytium-inducing strains) in cultured lines of
CD4+ T lymphocytes and with the development of
immunodeficiency (40).
The genetic diversity of lentiviruses circulating in the bloodstream or
in tissues or tissue fluids has thus far been characterized by
sequencing portions of env amplified from extracted nucleic acids (6, 24) and by heteroduplex mobility analysis
(13). Much has been learned in this way about populations of
lentiviruses, but there is little understanding as yet of the
interactions in vivo between the individual members that comprise
quasispecies and their host cells. To address this gap in our
understanding of lentivirus pathogenesis, we have devised and describe
in this report an in situ hybridization (ISH) approach to investigating the replication of individual genotypes that defines cellular and
tissue tropisms and sites of replication at single-cell resolution.
 |
MATERIALS AND METHODS |
Animals and virus.
Rhesus macaques used for these studies
were housed at the BIOQUAL animal facility (Rockville, Md.), and all
animal experiments were performed in accordance with the National
Institutes of Health guidelines on the care and use of laboratory
animals. Detailed descriptions of the animals, clinicopathological
findings, and ISH findings with representative probes are presented
separately (36). Briefly, juvenile rhesus macaques were
inoculated with 10 rhesus macaque infectious doses of cell-free
SIVdeltaB670 grown in human peripheral blood mononuclear cells
(34). This inoculum was an aliquot of the same stock used
previously (34) that on repeated passage in peripheral blood
mononuclear cells maintains the same major genotypes and predominant
clonotypes (clones 3 and 12 [see below] as the parent (3).
Prior to sacrifice, animals received ketamine (20 mg/kg) and were
subsequently anesthetized with ketamine-acepromazine (10 mg/kg).
Animals were then perfused transcardially with phosphate-buffered
saline (PBS; approximately 2 liters/kg of body weight), 1% formalin in
PBS (400 ml/kg), and 4% formalin in PBS (approximately 1.5 liters/kg).
Tissue specimens were removed and fixed overnight in 4%
paraformaldehyde-PBS, cryopreserved by sequential immersion in 10 to
20% sucrose in PBS over 48 h, and snap frozen in isopentane
cooled to
70°C.
Animals diagnosed with AIDS were euthanized at 4.5 to 6.5 months
postinoculation. Signs of disease included chronic diarrhea unresponsive to antibiotics, wasting, fever, or pneumonia. At the time
of sacrifice, the animals were moribund and had plasma antigenemia
levels of between 25 and 40 ng/ml as determined by antigen capture
enzyme-linked immunosorbent assay (Coulter). Animals that had no signs
of AIDS 5.5 to 6.5 months after inoculation were also sacrificed to
serve as infected, asymptomatic controls.
ISH.
ISH for detection of SIV RNA with antisense
oligonucleotide probes was performed as described previously
(36). Briefly, 14-µm sections were cut from cryopreserved
tissues, thaw mounted onto 3-aminopropyltriethoxysilane-coated
microscope slides, and stored at
70°C until use. Sections were then
postfixed in 4% paraformaldehyde-PBS for 20 min, washed in 70%
ethanol for 20 min, and dehydrated in graded ethanols. Pretreatments
consisted of either of two regimens, both providing equivalent ISH
results (data not shown). The first pretreatment consisted of
incubation for 20 min each, in 0.2 N HCl at ambient temperature, with
2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate) at 70°C and 2 mM CaCl2-20 mM Tris (pH 7.5)-10 µg of proteinase
K per ml at 37°C; two 5-min washes in diethyl pyrocarbonate
(DEPC)-treated distilled H2O (dH2O); and
acetylation in 0.25% acetic anhydride-0.1 M triethanolamine (pH 8.0).
The second pretreatment protocol is described in the description of
combined ISH and immunuhistochemical (IHC) staining. Following
dehydration in graded ethanols, 300,000 to 500,000 cpm of
35S-labeled probe in 10 µl of hybridization mix
(35) was spread on the section under a coverslip, which was
then sealed with rubber cement and hybridized at 37°C for 18 h.
Sections were then washed twice through 2× SSC (room temperature, 5 min), once through 0.2× SSC (room temperature, 5 min), once through
0.2× SSC (54°C, 1 h), and extensively (2 days) in hybridization
wash medium (0.6 M NaCl, 10 mM Tris [pH 7.4], 1 mM EDTA, 5 mM
dithiothreitol, 50% formamide). Sections were dehydrated in graded
ethanols containing 0.3 M ammonium acetate, air dried, coated with
NTB-2 emulsion (Kodak, Rochester, N.Y.), and exposed at 10°C for 3 to
14 days. Oligonucleotide probes were 3'-end labeled with
[35S]dCTP (NEN/DuPont), using terminal
deoxynucleotydaltransferase, to specific activities of 5 × 109 to 8 × 109 cpm/µg.
The sequences of SIV-specific oligonucleotide probes were based on
previously published sequence analyses of the SIVdeltaB670
isolate
(
3) and are displayed in Fig.
1. The target sequences
of probe
V1.clone.2 are within the
env V1 corresponding to nucleotide
positions 6941 to 7062 of the SIVsmmH4 proviral sequence
(
25).
For ISH analysis of
env RNA expression in
COS cells and previous
analyses of SIV RNA expression in the tissue
specimens described
here, a
PvuII restriction fragment
(nucleotide positions 6600
to 8286) from the SIVmacBK28 proviral clone
(
26) was subcloned
into the
SmaI site of pGEM4Z
(Promega).
35S-labeled antisense and sense riboprobes were
synthesized by using
a SP6/T7 Maxiscript kit (Ambion) with
[
35S]UTP (NEN/DuPont) included in the transcription
reaction.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
SIV genotype-specific oligonucleotide probes. (A)
Alignment of the V1 regions of SIVdeltaB670 clones 2, 3, 6, and 12 reported by Amedee et al. (3). Dashes represent sequence
identity with clone 2, dots represent sequence gaps, and lowercase
letters represent nucleotide insertions. The regions to which the
genotype-specific probes were complementary are boxed. (B) Sequences
and properties of SIV genotype-specific probes. The melting temperature
(Tm) was calculated as follows: 16.6 log10 [Na+] + 81.5 + 41.5 [% GC] 675/length % mismatch 0.65 [% formamide], for
hybridization in 0.6 M NaCl and 45% formamide, length of 30 or 32, and
0% mismatch.
|
|
Plasmids and transfections.
Plasmids containing the 1.9-kb
env inserts from clones 2 to 12 (3) were
restriction digested with EcoRI. Agarose gel-purified env inserts were then ligated to the eukaryotic expression
vector pCMV-5 (4).
Individual plasmids were electroporated into COS cells (1,000 µF, 300 V in serum-free OptiMem [Gibco]). At 48 h after transfection,
cells were pelleted by centrifugation (500 ×
g),
washed with cold
PBS, and resuspended in PBS at a density of
approximately 2 ×
10
4 cells/4 µl. Then 4 µl of
each sample culture was spotted onto
slides coated with
3-aminopropyltriethoxysilane, air dried, fixed
for 20 min in freshly
prepared, PBS-buffered 4% paraformaldehyde
(pH 7.1 to 7.2), and washed
and dehydrated in graded ethanols.
Combined ISH and IHC staining for cell type markers.
To
unambiguously identify the cell types expressing SIVdeltaB670 RNAs, ISH
and IHC were performed on the same tissue sections. Tissue sections
were heated in a microwave oven in 0.01 M citrate buffer (pH 6.0) for
10 min at 800 W with interruptions at 1- to 2-min intervals to replace
lost liquid. Sections were cooled at room temperature for 30 min,
rinsed in DEPC-treated dH2O, acetylated, and dehydrated in
graded ethanols. After ISH and stringent hybridization washes, sections
were rinsed in 1× PBS twice for 5 min. Nonspecific antibody binding
sites on sections were blocked by incubation for 1 h in 1× PBS
with 5% nonfat dry milk (PBS-NFDM). Excess blocking solution was wiped
away and replaced with antigen-specific primary antibody for 1 h.
Sections were washed in 1× PBS twice for 5 min each time, and cells to
which the primary antibodies bound were detected by the avidin-biotin
complex method (ABC kit; Vector Laboratories) with
3,3'-diaminobenzidine as the substrate. The sections were coated with
NTB-2 emulsion (Kodak), exposed, developed, and counterstained lightly
with hematoxylin. All reagents for combined ISH and IHC were made with
DEPC-treated dH2O or were treated directly with DEPC. All
incubations for IHC were performed at room temperature, and all
diluents were PBS-NFDM. Primary antibodies were specific for CD68
(murine monoclonal KP1; Dako) or CD3 (rabbit polyclonal serum; Dako).
RT-PCR and sequence analyses.
Nested reverse transcription
(RT)-PCR for plasma viral RNA, subcloning, and DNA sequence analyses
were performed as described previously (3). Pairwise
nucleotide sequence comparisons of V1 clones 2 to 12 and
genotype-specific probes were performed with the EGCG extensions (Peter
Rice, The Sanger Centre, Cambridge, England) to the Wisconsin package
(Genetics Computer Group, Madison, Wis.).
 |
RESULTS |
To analyze the replication of individual genotypes in vivo, we
designed genotype-specific probes that could be hybridized in situ to
detect expression of particular genotypes in cells in tissue sections.
We developed and applied this method in an experimental model of
lentivirus infection that has relevant and important parallels to HIV
infection, including immunodeficiency and neurological disease
(15). A cohort of juvenile macaques was inoculated with a
pathogenic isolate of SIV (deltaB670 [34]). Sequences
in the first and most variable region (V1) of the env gene
have been determined previously in a separate stock of SIVdeltaB670 from which the stock used here was expanded and in viruses in the blood
and tissues of infected animals (3). We focused on V1
initially because it differs to the greatest extent between genotypes
and is a major determinant of tropism (2, 30, 32, 37).
Although there are multiple V1 genotypes in SIVdeltaB670 isolates, we
concentrated on four V1 clones (clones 2, 3, 6, and 12) because they
represent 88% of the V1 sequences identified in infected animals and
100% (clone 12) of the V1 sequences transmitted in utero
(3).
We aligned the V1 sequences of these four clones to identify the
regions of greatest diversity, such as regions with insertions or
deletions, among the different genotypes (Fig. 1A), and we designed and
synthesized antisense oligonucleotide probes of 30 to 32 nucleotides
targeted to these regions. The four probes were comparable in GC
content and melting temperature (Fig. 1B), were similar in size, and
could be labeled to specific activities equivalent to those of probes
that we have used to detect spliced and unspliced SIV RNAs in tissues
(35). We documented the specificity of these probes in COS
cells transiently transfected with eukaryotic expression vectors
containing recombinant inserts derived from the env clones. After ISH and autoradiography, the hybridization signal of hundreds of
(black) silver grains over background was limited to cells transfected
with the cognate target sequences (Fig.
2). There was no appreciable binding of
probes to cells expressing heterologous V1 sequences with up to 93%
sequence identity, even though env sequences from clones 2 through 12 were expressed at high levels in the transfected COS cells
and could be detected with a riboprobe complementary to the
env gene (not shown).

View larger version (98K):
[in this window]
[in a new window]
|
FIG. 2.
Specific ISH detection of SIV RNAs with antisense
oligonucleotide probes. Plasmids expressing the env
fragments from the indicated SIVdeltaB670 clone were electroporated
into COS cells and env V1-targeted antisense oligonucleotide
probes were hybridized in situ to expressed RNAs. Autoradiographs were
exposed for 1 day. Magnification, ×78. The percent sequence homology
is for the best-matched 30-nucleotide target in the corresponding V1.
|
|
We used the genotype-specific probes in ISHs to identify the cells and
anatomic sites of replication of each of the four genotypes in six
rhesus macaques inoculated with uncloned SIVdeltaB670. The animals were
euthanized 2.5 to 6 months postinoculation, when they developed AIDS,
or at 6 months postinoculation in a control, infected asymptomatic
group. We detected, by ISH with riboprobes complementary to
pol and env, cells with abundant viral RNA in lymphoid tissues, nervous system, lung, and gut, as well as viral RNA
in virions on the surfaces of follicular dendritic cells in germinal
centers (Table 1). Peripheral and tissue
viral loads were uniformly higher in all tissues in the animals that
developed AIDS (36).
The four V1 variants replicated to different extents and with
distinctive patterns within and between animals, and in general, the
most prevalent genotypes in the tissues were also the most prevalent in
plasma (Table 1). The discrete microanatomical sites of replication and
relative prevalences of the four V1 variants in spleen are illustrated
in Fig. 3. Clones 2 and 6 were found more
frequently in the macrophage-rich red pulp areas, whereas a much
greater proportion of cells infected with clone 3 or 12 variants was
found in the T-lymphocyte-rich periarteriolar lymphoid sheaths of the
white pulp, although replication was not restricted to white pulp. This
was one indication that these variants were dual tropic in vivo, a
finding which we document more directly below. V1 clones 3 and 12 replicated in more cells and organ systems, and to higher levels in the
animals with AIDS, than clone 2 or 6, and clone 3 was the only variant
that replicated in the asymptomatic animals, with the exception of rare
cells in the thymus in which we detected clone 12 RNA (Table 1). These
findings are consistent with the observation that clones 3 and 12 are
the most frequently found variants in infected animals (3)
and with the enigmatic association of clone 3 with infections that
progress slowly to manifest illness (2a).

View larger version (98K):
[in this window]
[in a new window]
|
FIG. 3.
Spatial distribution of cells productively infected with
SIVdeltaB670 variants in spleen tissue from animal MO74. Subjacent
tissue sections were hybridized with the four genotype-specific probes
(Table 1), and the gross locations of the foci of infected cells (e.g.,
insets) detected with individual probes are indicated by the overlaid
colors.
|
|
Clonotypic viral gene expression also occurred in spatially restricted
and defined patterns in nonlymphoid tissues; for example, we found many
cells with high levels of clone 12 RNA in regions of the brain or gut
in which there was no evidence of replication of clone 3 (or clones 2 and 6) (Fig. 4). Levels of viral gene expression were comparable between genotypes and comparable to those
determined for sequences surrounding the major subgenomic splice donor,
1,200 copies of RNA/cell (35). This we determined by
counting silver grains over cells by quantitative image analysis (23), and we found on average that there were approximately 1,600 copies of V1 clonotypic RNA per cell (not shown).

View larger version (95K):
[in this window]
[in a new window]
|
FIG. 4.
Replication of V1 clones 3 and 12 at discrete sites in
the gut and brain in animal M086. ISH to subjacent tissue sections with
the antisense V1.clone.3 or V1.clone.12 probe demonstrated clone 12 replication in the shown regions of the tissue specimen.
Autoradiographs were exposed for 7 days. Magnification, ×44.
|
|
To address the issue of the relationship of genetic diversity to
cellular tropisms in vivo, we combined ISH with genotype-specific probes and IHC staining to identify the types of cells infected by the
variants. Infection with clone 12 has previously been associated with
encephalitis and AIDS; clone 12 is the predominant viral strain
isolated from infected tissues and replicates in vitro in primary
rhesus macrophages (3). We determined the cellular tropisms
of clone 12 and clone 3 in vivo by staining cells in the macrophage
lineage with antibody to CD68 and staining T lymphocytes with antibody
to CD3. In the central nervous system, most productively infected cells
have been shown to be macrophages and microglia (8, 27), and
not unexpectedly, we detected high levels of clone 3 and clone 12 RNA
in cells that stained with anti-CD68 antibody (Fig.
5). There were, however, occasional
infected CD3+ T lymphocytes (not shown). In lymphoid
tissues and gut, we found evidence of viral replication of both clones
in T lymphocytes (Fig. 5) and in macrophages (not shown). We thus
document by double-label ISH with genotype-specific probes that the
predominant replicating variants in the SIVdeltaB670 isolate are dual
tropic in vivo.

View larger version (89K):
[in this window]
[in a new window]
|
FIG. 5.
Dual tropism of V1 clones 3 and 12. In the central
nervous system (CNS) or gastrointestinal tract, macrophages (MØ) were
identified by IHC staining with anti-CD68 antibodies, and T lymphocytes
were detected with anti-CD3 serum. Clonotypic viral RNA was similarly
detected with the genotype-specific probes. Autoradiographs were
exposed times for 12 to 14 days. Original magnification, ×122 to
×190.
|
|
 |
DISCUSSION |
We have shown for the first time that individual, expressed
genotypes comprising a primate lentivirus quasispecies can be tracked
at single-cell resolution in tissue sections. SIVs harbored within
productively infected cells in tissues, whose V1 sequences were more
than 90% homologous, were distinguished in vivo to reveal their
cellular and anatomic sites of replication. Previously, DNA sequence
analysis of HIV type 1 proviral DNA in individual microdissected
splenic white pulps provided evidence of spatial compartmentalization
of HIV genotypes (10) and suggested that local foci of
similar genotypes arose due to the recruitment and proliferation of
antigen-specific T lymphocytes. We now document compartmentalization
that extends to the level of individual cells expressing viral RNA and
antigen (not shown) in the spleen and other organs that can readily
account for founder effects and differences in lentivirus quasispecies
between and within organ systems in studies limited in analysis to
viral DNA (10, 12, 20, 38).
In addition to spatially defined patterns of replication within an
organ, widespread dissemination also varied between the V1 genotypes.
Only the two highly virulent clone 3 and 12 variants were widely
disseminated, and the cells productively infected with these viruses
comprised the vast majority of those expressing viral RNA (data not
shown). The predominance of these clonotypes in infection with an
inoculum obtained by passage of the original stock (3)
attests to the replicative fitness of these two variants. The other
members of this quasispecies did not disseminate throughout the animals
despite replication in the spleen and the immunocompromised status of
the animals and, therefore, presumably permissive environment for viral
dissemination. It is possible that local, residual immune responses to
specific viral epitopes expressed by certain env genes
contributes to the lack of dissemination of genotypes other than clones
3 and 12. Alternatively, there may be depletion of a specific subset of
host target cells that these variants require for propagation, or there
may be restrictions on the abilities of some variants to use alternate
entry cofactors such as the
-chemokine receptors (1, 11, 14,
17, 18, 21). In support of this view, the expression of the CCR5
and CXCR4 coreceptors is differentially regulated on naive and memory T
lymphocytes (5) and on T lymphocytes simultaneously
stimulated through CD3 and CD28 (7).
We did not observe tissue-specific expression of viral genotypes except
in the spleen, where there was evidence of replication of all four
variants (Table 1 and Fig. 3). This was nonetheless insufficient to
alter the predominance of clones 3 and 12 in the plasma or in other
tissues (Table 1). It is possible that further PCR analyses of
peripheral blood and proviral DNA from tissues will detect replication
of other variants such as clones 2 and 6.
Our observation that both of the pathogenic variants, clones 3 and 12, were dual-tropic for macrophages and T lymphocytes suggests that their
abilities to use coreceptors on these alternate cell types contributes
to their ability to replicate to high levels and disseminate widely.
Specific changes in their env sequences might allow the use
of not only CCR5, which is used by all SIVs analyzed to date (9,
19, 29), including clone 3 (19), but also other
coreceptors, an issue that we are now investigating. In this study as
well as others (3), clone 3 is a predominant replicating
variant, but it also is the most frequently detected genotype in
asymptomatic animals (Table 1; reference 2a). This dual phenotype implies the involvement of either additional viral determinants of outcome outside the V1 region of env or
different phenotypes dependent on host factors. We cannot rule out the
possibility that changes outside V1, which our probes will not detect,
account for the dual tropism of clones 3 and 12 or the dual phenotype of clone 3. It will be necessary to examine a larger number of animals
and animals in the acute phase of infection to ascertain whether the
dual tropism of these variants is an inherent biological feature or
whether it evolves during the course of infection in vivo. With the
experimental approach that we describe here, it should be possible to
investigate how interactions between cells and viruses with defined
differences in specific regions of env and other genes
affect viral transmission, dissemination, pathogenesis, and response to
treatment.
 |
ACKNOWLEDGMENTS |
We thank Rita Vertesi and Mary Zupancic for expert technical
assistance, James I. Mullins for providing pBK28, and Ernest Retzel for
his generous help in synthesizing oligonucleotides. We also thank
Kathryn Staskus and Steve Wietgrefe for helpful discussions and Colleen
O'Neill, Melodie Bahan, and Tim Leonard for assistance in preparation
of the manuscript.
T.A.R. was a Pediatric AIDS Foundation Scholar during these studies. We
thank the NIH and Volkswagen Foundation for support.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, University of Minnesota Medical School, 420 Delaware St., S.E., Box 196UMHC, Minneapolis, MN 55455. Phone: (612) 624-4442. Fax:
(612) 626-0623. E-mail: micro{at}lenti.med.umn.edu.
Present address: Immunopathology Unit, Glaxo Wellcome Medicines
Research Center, Stevenage, Hertfordshire SG1 2NY, United Kingdom.
 |
REFERENCES |
| 1.
|
Alkhatib, G.,
C. Combadiere,
C. C. Broder,
Y. Feng,
P. E. Kennedy,
P. M. Murphy, and E. A. Berger.
1996.
CC CKR5: a Rantes, MIP-1 , MIP-1 receptor as a fusion cofactor for macrophage-tropic HIV-1.
Science
272:1955-1958[Abstract].
|
| 2.
|
Almond, N.,
A. Jenkins,
A. G. Heath, and P. Kitchin.
1993.
Sequence variation in the env gene of simian immunodeficiency virus recovered from immunized macaques is predominantly in the V1 region.
J. Gen. Virol.
74:865-871[Abstract/Free Full Text].
|
| 2a.
| Amedee, A. Unpublished observation.
|
| 3.
|
Amedee, A. M.,
N. Lacour,
J. L. Gierman,
L. N. Martin,
J. E. Clements,
R. Bohm, Jr.,
R. M. Harrison, and M. Murphey-Corb.
1995.
Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally.
J. Virol.
69:7982-7990[Abstract].
|
| 4.
|
Anderson, S.,
D. N. Davis,
H. Bahlback,
H. Jornvall, and D. W. Rusell.
1989.
Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme.
J. Biol. Chem.
264:8222-8229[Abstract/Free Full Text].
|
| 5.
|
Bleul, C. C.,
L. J. Wu,
J. A. Hoxie,
T. A. Springer, and C. R. Mackay.
1997.
The coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.
Proc. Natl. Acad. Sci. USA
94:1925-1930[Abstract/Free Full Text].
|
| 6.
|
Burns, D. P. W., and R. C. Desrosiers.
1991.
Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys.
J. Virol.
65:1843-1854[Abstract/Free Full Text].
|
| 7.
|
Carroll, R. G.,
J. L. Riley,
B. L. Levine,
Y. Feng,
S. Kaushal,
D. W. Ritchey,
W. Bernstein,
O. S. Weislow,
C. R. Brown,
E. A. Berger,
C. H. June, and D. C. St. Louis.
1997.
Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells.
Science
276:273-276[Abstract/Free Full Text].
|
| 8.
|
Chakrabarti, L.,
M. Hurtrel,
M.-A. Maire,
R. Vazeux,
D. Dormont,
L. Montagnier, and B. Hurtrel.
1991.
Early viral replication in the brain of SIV-infected rhesus monkeys.
Am. J. Pathol.
139:1273-1280[Abstract].
|
| 9.
|
Chen, Z.,
P. Zhou,
D. D. Ho,
N. R. Landau, and P. A. Marx.
1997.
Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry.
J. Virol.
71:2705-2714[Abstract].
|
| 10.
|
Cheynier, R.,
S. Henrichwark,
F. Hadida,
E. Pelletier,
E. Oksenhendler,
B. Autran, and S. Wain-Hobson.
1994.
HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes.
Cell
78:373-387[Medline].
|
| 11.
|
Choe, H.,
M. Farzan,
Y. Sun,
N. Sullivan,
B. Rollins,
P. D. Ponath,
L. Wu,
C. R. Mackay,
G. LaRosa,
W. Newman,
N. Gerard,
C. Gerard, and J. Sodroski.
1996.
The -chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.
Cell
85:1135-1148[Medline].
|
| 12.
|
Delassus, S.,
R. Cheynier, and S. Wain-Hobson.
1991.
Nonhomogeneous distribution of human immunodeficiency virus type 1 proviruses in the spleen.
J. Virol.
66:5642-5645[Abstract/Free Full Text].
|
| 13.
|
Delwart, E. L.,
E. G. Shpaer,
J. Louwagie,
F. E. McCutchan,
M. Grez,
H. Rubsamen-Waigmann, and J. I. Mullins.
1993.
Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes.
Science
262:1275-1261.
|
| 14.
|
Deng, D.,
R. Liu,
W. Ellmeier,
S. Choe,
D. Unutmaz,
M. Burkhart,
P. T. J. Schall,
D. R. Littman, and N. R. Landau.
1996.
Identification of a major co-receptor for primary isolates of HIV-1.
Nature
381:661-666[Medline].
|
| 15.
|
Desrosiers, R. C.
1990.
The simian immunodeficiency viruses.
Annu. Rev. Immunol.
8:557-578[Medline].
|
| 16.
|
Di Stefano, M.,
S. Wilt,
F. Gray,
M. Dubois-Dalcq, and F. Chiodi.
1996.
HIV type 1 V3 sequences and the development of dementia during AIDS.
AIDS Res. Hum. Retroviruses
12:471-476[Medline].
|
| 17.
|
Doranz, B. J.,
J. Rucker,
Y. Yi,
M. Samson,
S. C. Peiper,
M. Parmentier,
R. G. Collman, and R. W. Doms.
1996.
A dual-tropic primary HIV-1 isolate that uses fusin and the -chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.
Cell
85:1149-1158[Medline].
|
| 18.
|
Dragic, T.,
V. Litwin,
G. P. Allaway,
S. R. Martin,
Y. Huang,
K. A. Nagashima,
C. Cayanan,
P. J. Maddon,
R. A. Koup,
J. P. Moore, and W. A. Paxton.
1996.
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.
Nature
381:667-673[Medline].
|
| 19.
|
Edinger, A. L.,
A. Amedee,
K. Miller,
B. J. Doranz,
M. Endres,
M. Sharron,
M. Samson,
Z.-H. Lu,
J. E. Clements,
M. Murphey-Corb,
S. C. Peiper,
M. Parmentier,
C. C. Broder, and R. W. Doms.
1997.
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains.
Proc. Natl. Acad. Sci. USA
94:4005-4010[Abstract/Free Full Text].
|
| 20.
|
Epstein, L. G.,
C. Kuiken,
B. M. Blumberg,
S. Hartman,
L. R. Sharer,
M. Clement, and J. Goudsmit.
1991.
HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies.
Virology
180:583-590[Medline].
|
| 21.
|
Feng, Y.,
C. C. Broder,
P. E. Kennedy, and E. A. Berger.
1996.
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor.
Science
272:872-877[Abstract].
|
| 22.
|
Fiore, J. R.,
A. Bjorndal,
K. A. Peipke,
M. Di Stefano,
G. Angarano,
G. Pastore,
H. Gaines,
E. M. Fenyo, and J. Albert.
1994.
The biological phenotype of HIV-1 is usually retained during and after sexual transmission.
Virology
204:297-303[Medline].
|
| 23.
|
Haase, A. T.,
K. Henry,
M. Zupancic,
G. Sedgewick,
R. A. Faust,
H. Melroe,
W. Cavert,
K. Gebhard,
K. Staskus,
Z.-Q. Zhang,
P. J. Dailey,
H. H. Balfour, Jr.,
A. Erice, and A. S. Perelson.
1996.
Quantitative image analysis of HIV-1 infection in lymphoid tissue.
Science
274:985-989[Abstract/Free Full Text].
|
| 24.
|
Hahn, B.,
G. M. Shaw,
M. E. Taylor,
R. R. Redfield,
P. D. Markham,
S. Z. Salahuddin,
F. Wong-Staal,
R. C. Gallo,
E. S. Parks, and W. P. Parks.
1986.
Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.
Science
232:1548-1553[Abstract/Free Full Text].
|
| 25.
|
Hirsch, V. M.,
R. A. Olmsted,
M. Murphey-Corb,
R. H. Purcell, and P. R. Johnson.
1989.
An African primate lentivirus (SIVsm) closely related to HIV-1.
Nature
339:389-392[Medline].
|
| 26.
|
Kornfeld, H.,
N. Riedel,
G. A. Viglianti,
V. Hirsch, and J. Mullins.
1987.
Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses.
Nature
326:610-613[Medline].
|
| 27.
|
Lackner, A. A.,
M. O. Smith,
R. J. Munn,
D. J. Martfeld,
M. B. Gardner,
P. A. Marx, and S. Dandekar.
1991.
Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys.
Am. J. Pathol.
139:609-621[Abstract].
|
| 28.
|
Larder, B. A., and S. D. Kemp.
1989.
Multiple mutations in HIV-1 reverse transcriptase confer high level resistance to zidovudine.
Science
246:1155-1158[Abstract/Free Full Text].
|
| 29.
|
Marcon, L.,
H. Choe,
K. A. Martin,
M. Farzan,
P. D. Ponath,
L. Wu,
W. Newman,
N. Gerard,
C. Gerard, and J. Sodroski.
1997.
Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239.
J. Virol.
71:2522-2527[Abstract].
|
| 30.
|
Mori, K.,
D. J. Ringler,
K. Toshiaki, and R. C. Desrosiers.
1992.
Complex determinants of macrophage tropism in Env of simian immunodeficiency virus.
J. Virol.
66:2067-2075[Abstract/Free Full Text].
|
| 31.
|
Murphey-Corb, M.,
L. N. Martin,
S. R. S. Rangan,
G. B. Baskin,
B. J. Gormus,
R. H. Wolf,
W. A. Andes,
M. West, and R. C. Montelaro.
1986.
Isolation of a HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys.
Nature
321:435-437[Medline].
|
| 32.
|
Palmer, C.,
P. Balfe,
D. Fox,
J. C. May,
R. Frederickson,
E.-M. Fenyo, and J. A. McKeating.
1996.
Functional characterization of the V1V2 region of human immunodeficiency virus type 1.
Viroloy
220:436-449[Medline].
|
| 33.
|
Power, C.,
J. C. McArthur,
R. T. Johnson,
D. E. Griffin,
J. D. Glass,
S. Perryman, and B. Chesebro.
1994.
Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences.
J. Virol.
68:4643-4649[Abstract/Free Full Text].
|
| 34.
|
Rausch, D. M.,
M. P. Heyes,
E. A. Murray,
J. Lendvary,
L. R. Sharer,
J. M. Ward,
S. Rehm,
D. Nohr,
E. Weihe, and L. E. Eiden.
1994.
Cytopathologic and neurochemical correlates of progression to motor/cognitive impairment in SIV-infected rhesus monkeys.
J. Neuropathol. Exp. Neurol.
53:165-175[Medline].
|
| 35.
|
Reinhart, T. A.,
M. J. Rogan,
G. A. Viglianti,
D. M. Rausch,
L. E. Eiden, and A. T. Haase.
1997.
A new approach to investigating the relationship between productive infection and cytopathicity in vivo.
Nat. Med.
3:218-221[Medline].
|
| 36.
|
Reinhart, T. A.,
M. J. Rogan,
A. M. Amedee,
M. Murphey-Corb,
D. M. Rausch,
L. E. Eiden, and A. T. Haase.
1997.
Simian immunodeficiency virus burden in tissues and cellular compartments during clinical latency and AIDS.
J. Infect. Dis.
176:1198-1208[Medline].
|
| 37.
|
Rudensey, L. M.,
J. T. Kimata,
R. E. Benveniste, and J. O. Overbaugh.
1995.
Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population.
Virology
207:528-542[Medline].
|
| 38.
|
Sala, M.,
G. Zambruno,
J.-P. Vartanian,
A. Marconi,
U. Bertazzoni, and S. Wain-Hobson.
1994.
Spatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection.
J. Virol.
68:5280-5283[Abstract/Free Full Text].
|
| 39.
|
Salinovich, O.,
S. L. Payne,
R. C. Montelaro,
K. A. Hussain,
C. J. Issel, and K. L. Schnorr.
1986.
Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.
J. Virol.
57:71-80[Abstract/Free Full Text].
|
| 40.
|
Schuitemaker, H.,
M. Koot,
N. A. Kootstra,
M. W. Dercksen,
R. E. Y. De Goede,
R. P. Van Steenwijk,
J. M. A. Lange,
J. K. M. E. Schattenkerk,
F. Miedema, and M. Tersmette.
1992.
Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations.
J. Virol.
66:1354-1360[Abstract/Free Full Text].
|
| 41.
|
Wolinsky, S. M.,
B. T. M. Korber,
A. U. Neumann,
M. Daniels,
K. J. Kunstman,
A. J. Whetsell,
M. R. Furtado,
Y. Cao,
D. D. Ho,
J. T. Safrit, and R. A. Koup.
1996.
Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection.
Science
272:537-542[Abstract].
|
| 42.
|
Zhu, T.,
H. Mo,
N. Wang,
D. S. Nam,
Y. Cao,
R. A. Koup, and D. D. Ho.
1993.
Genotypic and phenotypic characterization of HIV-1 in patients with primary infection.
Science
261:1179-1181.
|
J Virol, January 1998, p. 113-120, Vol. 72, No. 1
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Finzi, D., Plaeger, S. F., Dieffenbach, C. W.
(2006). Defective Virus Drives Human Immunodeficiency Virus Infection, Persistence, and Pathogenesis.. CVI
13: 715-721
[Full Text]
-
Rychert, J., Lacour, N., Amedee, A. M.
(2006). Genetic Analysis of Simian Immunodeficiency Virus Expressed in Milk and Selectively Transmitted through Breastfeeding.. J. Virol.
80: 3721-3731
[Abstract]
[Full Text]
-
Zhang, Z.-Q., Wietgrefe, S. W., Li, Q., Shore, M. D., Duan, L., Reilly, C., Lifson, J. D., Haase, A. T.
(2004). Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA
101: 5640-5645
[Abstract]
[Full Text]
-
Babas, T., Munoz, D., Mankowski, J. L., Tarwater, P. M., Clements, J. E., Zink, M. C.
(2002). Role of Microglial Cells in Selective Replication of Simian Immunodeficiency Virus Genotypes in the Brain. J. Virol.
77: 208-216
[Abstract]
[Full Text]
-
Rouzine, I. M., Rodrigo, A., Coffin, J. M.
(2001). Transition between Stochastic Evolution and Deterministic Evolution in the Presence of Selection: General Theory and Application to Virology. Microbiol. Mol. Biol. Rev.
65: 151-185
[Abstract]
[Full Text]
-
Rouzine, I. M., Coffin, J. M.
(1999). Search for the Mechanism of Genetic Variation in the pro Gene of Human Immunodeficiency Virus. J. Virol.
73: 8167-8178
[Abstract]
[Full Text]
-
Rouzine, I. M., Coffin, J. M.
(1999). Linkage disequilibrium test implies a large effective population number for HIV in vivo. Proc. Natl. Acad. Sci. USA
96: 10758-10763
[Abstract]
[Full Text]
-
Miralles, R., Moya, A., Elena, S. F.
(1999). Effect of population patchiness and migration rates on the adaptation and divergence of vesicular stomatitis virus quasispecies populations. J. Gen. Virol.
80: 2051-2059
[Abstract]
[Full Text]